Automated, closed, integrated process development and manufacturing for CAR T cells and NK cells
Manufacturing Sophisticated Solutions
OmniaBio is uniquely equipped to pioneer sophisticated solutions to complex and nuanced manufacturing challenges for cellular immunotherapies. We leverage both in-house expertise and key partnerships to solve technical bottlenecks. With our integrated platforms tailored to improve productivity and overcome the hurdles in immune cell proliferation and function, we are positioned to be your partner in delivering both autologous and allogeneic engineered cell therapies.
Services for Your Project Phase
Experts in optimization to ensure reliable scale-up to produce cell and gene therapies.
Our state-of-the-art facility is equipped with the tools and flexibility to manufacture your product at a commercial scale.
Providing a robust suite of analytical capabilities that are integrated through your product’s lifecycle to support the development process.
With in-depth knowledge, we can guide you through the regulatory landscape to approval.